Breathe Well Live Well
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Budesonide; Drug: Formoterol
Sponsor: Intech Biopharm Ltd.
Completed – verified July 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Condition: Asthma
Interventions: Drug: Symbicort; Drug: Generic Budesonide/Formoterol fumarate dihydrate; Drug: Placebo
Sponsor: Actavis Inc.
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler; Drug: SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler; Drug: NEUMOTEX 400 (Budesonide 400 mcg); Drug: Salbutamol 100 mcg pMDI
Sponsors: GlaxoSmithKline; Laboratorios Phoenix
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Asthma Chronic; Asthma Bronchial; Asthmatic
Interventions: Drug: Z7200; Drug: Symbicort® Turbohaler®; Drug: Placebo of Test product; Drug: Placebo of Reference Drug; Radiation: Functional Respiratory Imaging
Sponsors: FluidDA nv; Zambon SpA
Not yet recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: budesonide/formoterol ‘as needed’ + budesonide placebo bid; Drug: budesonode bid + terbutaline ‘as needed’
Sponsor: AstraZeneca
Not yet recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX; Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified February 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Astellas gets expanded approval for Symbicort asthma drug in Japan
Reuters TOKYO, June 22 (Reuters) – Astellas Pharma Inc saidon Friday it has received approval for additional use of itsSymbicort Turbuhaler drug treatment for adult … |
View full post on asthma – Google News
|
AstraZeneca Symbicort shows similar safety profile as Budesonide for asthma
Pharmaceutical Business Review AstraZeneca has published a new study that demonstrates that Symbicort Inhalation Aerosol 320/9 µg twice daily has a safety profile similar to Budesonide pressurized metered-dose inhaler (pMDI) 320 µg twice daily for asthma. SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows … |
View full post on asthma – Google News
|
Nycomed and Orion to sell generic Advair and Symbicort
Pharma Times The firms have signed an agreement which covers Orion's combination products for the treatment of asthma and chronic obstructive pulmonary disease, delivered by its new Easyhaler dry powder inhaler. In particular, Orion is developing copies of GSK's … Nycomed and Orion Corporation to collaborate on Easyhaler® for asthma and COPD |
View full post on asthma – Google News
|
Studies Ordered for Side Effects of Symbicort, Advair Diskus, Dulera, Foradil
AboutLawsuits.com Federal drug regulators have ordered that new studies be done to examine potential safety problems with a number of asthma drugs, including Advair, Symbicort, Dulera and Foradil. The FDA announced it was requiring the new clinical safety trials on … Already Available Asthma Medications FDA Orders Trials |
View full post on asthma – Google News